MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
CAS No. : 3690-10-6
MCE 国际站:Zebularine
产品活性:Zebularine (NSC309132; 4-Deoxyuridine)是DNA甲基转移酶抑制剂;也可抑制胞苷脱氨酶,Ki值为0.95 μM。
研究领域:Epigenetics | Autophagy
作用靶点:DNA Methyltransferase | Autophagy
In Vitro: Zebularine exerts its demethylation activity by stabilizing the binding of DNMTs to DNA, hindering the methylation and decreasing the dissociation, thereby trapping the enzyme and preventing turnover even at other sites. zebularine enhances tumor cell chemo- and radiosensitivity? and has antimitogenic and angiostatic activities. Zebularine inhibits DNA methylation and reactivates a gene previously silenced by methylation. Zebularine induces the myogenic phenotype in 10T1/2 cells, which is a phenomenon unique to DNA methylation inhibitors. Zebularine reactivates a silenced p16 gene and demethylated its promoter region in T24 bladder carcinoma cells. Zebularine treatment inhibits cell growth in a dose and time dependent manner with an IC50 of ~100 μM and 150 μM in MDA-MB-231 and MCF-7 cells, respectively, on 96 h exposure. At high doses zebularine induced changes in apoptotic proteins in a cell line specific manner manifested by alteration in caspase-3, Bax, Bcl2 and PARP cleavage. Zebularine is also a potent competitive inhibitor of the enzyme CR deaminase. The Ki for zebularine is 0.95μM.
In Vivo: Zebularine is only slightly cytotoxic to tumor-bearing mice. Compared with those in control mice, tumor volumes are statistically significantly reduced in mice treated with high-dose zebularine administered by intraperitoneal injection or by oral gavage. Zebularine also enhances the survival time of mice with L1210 leukemia treated with 5-AZA-CdR. About 27% of the mice treated with this drug combination has a survival time longer than the mice treated with only 5-AZA-CdR.
相关产品:Covalent Screening Library Plus | Natural Product-like Compound Library | Bioactive Compound Library Plus | Epigenetics Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Covalent Screening Library | Reprogramming Compound Library | Anti-diabetic Compound Library | Nucleotide Compound Library | Anti-Blood Cancer Compound Library | Transcription Factor-Targeted Library | AA-CW236 | Psammaplin A | SGI-1027 | Bobcat339 | DNMT-IN-1 | DNMT3A-IN-1 | Decitabine | Isofistularin-3 | ZIKV-IN-3 | DC-05 | (4aS,8aR)-NPD-001 | 6-Thioguanine | γ-Oryzanol | Dihydro-5-azacytidine | DC_517 | Laccaic acid A | Lomeguatrib | GSK3735967 | Levetiracetam-d6 | O6BTG-octylglucoside | RG108 | 6-Methyl-5-azacytidine | DY-46-2 | CM-579 | 5-Azacytidine | RSC133 | Levetiracetam
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物 | 寡核苷酸 | 抗体 | 点击化学
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。